Sermorelin has an unusual history: it was a genuine FDA-approved medicine, and then it was not — withdrawn in 2006 for commercial reasons, not safety ones. That history is now doing heavy lifting in marketing that would not otherwise survive scrutiny.
Sermorelin is a synthetic version of growth hormone-releasing hormone, the molecule your hypothalamus uses to tell your pituitary gland to release human growth hormone. Inject it and hGH rises. That much is straightforward pharmacology and is not in dispute.
What is in dispute — or rather, what is simply unestablished — is whether raising hGH in a healthy middle-aged adult produces the benefits sold alongside it: more muscle, less fat, better sleep, slower ageing. That leap from mechanism to outcome is the whole product.
How an approved drug became a compounded one
Sermorelin was approved and marketed for diagnosing and treating growth hormone deficiency in children. In 1996, one study reported that daily injection increased growth rate in 74% of children after six months. It worked, in that population, for that purpose.
The manufacturer later concluded it required higher doses than expected to be effective in children and was less effective than the alternatives available, and removed it from the market in 2006. FDA lists it as a discontinued drug product. Crucially, it was not withdrawn for reasons of safety or effectiveness — a distinction that matters legally, and one the marketing leans on hard.
Because it was previously approved and was not withdrawn on safety grounds, compounding pharmacies can prepare it — which is why it appears on telehealth menus at $99 to $149 a month. But FDA does not verify the safety, effectiveness or quality of compounded drugs, so what arrives at your door has not been assessed by anyone outside the supply chain selling it.
What sermorelin is actually supported for
Sermorelin claims against the evidence
The mechanism claim is well supported. The claims that sell the product to middle-aged adults are not.
Supported. Researchers have observed that sermorelin injection increases hGH in the bloodstream, which is the basis for its diagnostic use.
This was its approved indication. A 1996 study reported increased growth rate in 74% of treated children at six months, and a 1999 study also showed it stimulated growth.
Used off-label for this, with supporting research, but studies in adults are described in the literature as scarce.
Some research suggests improvements in lean mass, insulin sensitivity, wellbeing and libido, but this is not established and the healthy-adult use remains controversial.
Definitive research supporting an anti-ageing effect is lacking. This is the central marketing claim and the least supported one.
Ratings summarise the weight of published human evidence for the claim as marketed — not whether a substance is safe, and not a treatment recommendation. Tap a row for what the evidence consists of.
Side effects, interactions and who should not take it
Sermorelin is generally well tolerated. The most common side effects are at the injection site — irritation, itching, swelling, pain, redness or sensitivity — and these typically resolve without intervention. Less common effects include headache, flushing, dizziness, nausea, difficulty swallowing, sleepiness, rash, taste changes and restlessness.
Long-term risks are not known, which is a meaningful statement rather than a reassuring one: it reflects the absence of long-duration studies in healthy adults, not their reassuring results.
People who should avoid it or be screened carefully first include anyone allergic to sermorelin, anyone with untreated hypothyroidism, and anyone pregnant, planning pregnancy, or breastfeeding. Severe allergic reactions — hives, swelling of the face, mouth, tongue or lips, chest tightness or shortness of breath — require emergency care.
Sermorelin versus injected growth hormone
The obvious question is why not simply inject hGH. Many people do, and genetically engineered hGH is an effective treatment for growth deficiency in children and adults. But hGH therapy carries a heavier risk and side-effect profile, and it is tightly controlled — prescribing it for anti-ageing purposes is not lawful in the United States.
Sermorelin's pitch is that it works upstream, prompting your own pituitary to release hGH within its normal feedback loops rather than flooding the system from outside. That is a genuinely sensible argument for a gentler pharmacological profile. It is not, by itself, evidence that the downstream benefits materialise.
If you are considering it
- Ask whether your hGH or IGF-1 has actually been measured. Treating a deficiency you have not demonstrated is guesswork.
- Ask which pharmacy compounds it, and confirm it is a licensed 503A or 503B facility.
- Establish the full monthly cost including any membership, and what happens if you stop.
- Disclose every medication and supplement you take, particularly thyroid medication, insulin and steroids.
- Be clear with yourself about which claim you are buying — the hGH increase, which is real, or the anti-ageing outcome, which is not established.